GATEWAY FOR CANCER RESEARCH RAISED $4.2 MILLION AT ITS ANNUAL CURES GALA, “GATEWAY STUDIO 54”

CeeLo Green, SugarHill Gang, Tony Vincent and More Performed Live 
Melissa Peterman Emceed Annual Event Benefitting Cancer Clinical Trials and Lifesaving Research


SCHAUMBURG, IL – November 4, 2019 – 
Gateway for Cancer Research, a non-profit organization dedicated to funding transformational cancer research, raised $4.2 million at its Cures Gala, which featured a “Gateway Studio 54” theme this year. The annual gala was held on Saturday, November 2 at the Renaissance Schaumburg Convention Center Hotel in Schaumburg, IL.

Global philanthropists Dr. Stacie J. Stephenson (Vice Chairperson, Gateway) and Mr. Richard J Stephenson (Gateway’s Founder and Chairman) served as the evening’s hosts. Esteemed philanthropist Mr. Muneer Satter served as honorary co-chair.

“Cancer affects all of us and the generosity and dedication of those passionate about our urgent cause makes the vital research funded by Gateway possible, giving patients more comfort, more hope, and one of life’s most precious gifts – time,” said Dr. Stacie J. Stephenson. “This inspirational evening reflected the impact and continued promise of lifesaving research, and our tireless commitment to changing the face of cancer care.”

GRAMMY Award winning Singer/Songwriter/Producer CeeLo Green treated the crowd to his blockbuster hits and GRAMMY Hall of Fame recipients the SugarHill Gang delighted the crowd with their hit, “Rappers Delight.” Tony Vincent, ABBA Revisited and the Montreal Rhapsody Orchestra also performed live for guests.

Actress Melissa Peterman served as emcee for the evening, which was attended by special guests including Samantha Harris (EMMY Award winning TV host and model), Torrey DeVitto (NBC’s Chicago Med), Joe Minoso (NBC’s Chicago Fire), Marina Squerciati (NBC’s Chicago P.D.), Molly Bernard (NBC’s Chicago Med), Willa Fitzgerald (MTV’s Scream) and Alycia Mondavi (CEO and Co-Proprietor of Aloft and Dark Matter Wines).

“Gateway for Cancer Research is dedicated to funding transformational clinical trials for the patients we serve – courageous men, women and children facing cancer. We advance our mission in partnership with those who share our goal to end cancer as we know it,” said Michael Burton, Chief Executive Officer, Gateway for Cancer Research. “Gateway is an organization with a global reach, dedicated to making a difference on a global scale. No single organization or entity can bring cancer to heal alone. Our success is directly linked to the passion and generosity of our many donors. We are so very grateful for their support and commitment to our mission.”

Proceeds from the event will support transformational Phase I and Phase II clinical trials for cancers of all types. Since 1991, Gateway has raised more than $85 million for cancer research and funded 170+ studies benefitting over 5,500 patients worldwide. 99 cents of every dollar Gateway receives directly funds early phase clinical trials at renowned research institutions around the world.

99 cents of every dollar received directly funds cancer clinical trials

58

Current Gateway-funded clinical trials

170+

Clinical trials funded at leading institutions worldwide

$16.56

Funds one patient for one day at a Gateway-funded clinical trial

 
 

Mission Partners